Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nerve Growth Factor for visual blindness in optic nerve glioma
2008-001438-29Phase 2Completed
- Sponsor
- Policlinico Gemelli
- Start
- Jul 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Nerve growth factor in optic nerve glioma (OPG), sponsored by Policlinico Gemelli. Started Jul 2008; status: completed.
02
Drugs
Nerve growth factor
03
Conditions
optic nerve glioma (OPG)
Beyond the preview
Go deeper on 2008-001438-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001438-29.